Sagimet Biosciences Inc.

SGMT | NASDAQ

Price Alert Chart Builder DCF Calculator

$11.12

+$0.32 (+2.96%)

Sep 22, 2026, 1:04 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2M	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2M	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-15.82M	-11.71M	-10.77M	-14.33M	-11.93M	-19.87M	-18.2M	-16.9M	-10.59M	-8.77M	-9.47M	-7.45M	-7.06M	-6.77M	-7.39M	-7.69M	-7.24M	-8.74M
Interest Income	n/a	1.06M	-3.23M	1.43M	1.54M	1.69M	1.99M	2.28M	2.47M	2.14M	1.31M	1.1M	271K	180K	193K	218K	136K	6K
Pretax Income	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M	-7.47M	-7.1M	-8.74M
Net Income	-13.95M	-10.65M	-9.57M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M	-7.47M	-7.1M	-8.74M
Selling & General & Admin	4.28M	4.72M	4.03M	4.6M	4.68M	4.52M	3.98M	4.25M	4.28M	3.51M	3.81M	4.49M	2.38M	2.28M	1.54M	848K	867K	2.88M
Research & Development	11.54M	7M	6.73M	9.73M	7.25M	15.34M	14.22M	12.65M	6.31M	5.26M	5.66M	4.96M	4.68M	4.49M	5.85M	6.84M	6.37M	5.86M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	15.82M	11.71M	10.77M	14.33M	11.93M	19.87M	18.2M	16.9M	10.59M	8.77M	9.47M	9.45M	7.06M	6.77M	7.39M	7.69M	7.24M	8.74M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	15.82M	11.71M	10.77M	14.33M	11.93M	19.87M	18.2M	16.9M	10.59M	8.77M	9.47M	9.45M	7.06M	6.77M	7.39M	7.69M	7.24M	8.74M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	53.11M	32.56M	32.52M	32.46M	32.2M	32.2M	32.2M	32.14M	31.91M	29.04M	18.19M	18.19M	22.17M	22.17M	22.17M	22.17M	22.17M	22.17M
Shares Outstanding (Diluted)	53.11M	32.56M	32.52M	32.46M	32.2M	32.2M	32.2M	32.14M	31.91M	29.04M	18.19M	18.19M	22.17M	22.17M	22.17M	22.17M	22.17M	22.17M
EPS (Basic)	-0.26	-0.33	-0.29	-0.40	-0.32	-0.56	-0.50	-0.45	-0.25	-0.23	-0.45	-0.35	-0.31	-0.30	-0.32	-0.34	-0.32	-0.39
EPS (Diluted)	-0.26	-0.33	-0.29	-0.40	-0.32	-0.56	-0.50	-0.45	-0.25	-0.23	-0.45	-0.35	-0.31	-0.30	-0.32	-0.34	-0.32	-0.39
EBITDA	-13.95M	-10.65M	-12.19M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	2.14M	1.32M	-6.35M	-6.79M	-6.59M	193K	219K	136K	-8.7M
EBIT	-13.95M	-10.65M	-12.19M	-12.91M	-10.39M	-18.18M	-16.2M	-14.62M	-8.12M	-6.63M	-8.15M	-6.35M	-6.79M	-6.59M	-7.2M	-7.47M	-7.1M	-8.74M
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.77M	9.47M	n/a	n/a	n/a	7.39M	7.69M	7.24M	32K